Related Experiment Video

Updated: Aug 30, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Targeting tumor cells

Pantea Houshmand1, Albert Zlotnik

  • 1Neurocrine Biosciences, 10555 Science Center Drive, San Diego, CA 92121, USA.

Current Opinion in Cell Biology
|October 2, 2003
PubMed

Insights

Targeted cancer therapies using monoclonal antibodies are advancing rapidly. These "magic bullet" approaches identify specific tumor antigens, offering new treatment opportunities and challenges in oncology.

Area of Science:

  • Oncology
  • Immunology
  • Drug Development

Background:

  • The 'magic bullet' concept involves targeting specific antigens on tumor cells.
  • Monoclonal antibodies have emerged as a key therapeutic strategy in cancer treatment.
  • Advances in science and technology enable the development of targeted therapies.

Purpose of the Study:

  • To review the current status and future prospects of monoclonal antibodies in cancer therapy.
  • To discuss the opportunities and challenges associated with targeted cancer therapeutics.
  • To highlight the progression of antibody-based treatments from concept to clinical application.

Main Methods:

  • Review of recent scientific and technical developments in cancer therapeutics.
  • Analysis of the clinical progress of monoclonal antibodies in oncology.
  • Discussion of the 'magic bullet' concept in relation to targeted antigen identification.

Main Results:

  • Monoclonal antibody therapy for cancer has progressed beyond the proof-of-concept stage.
  • Numerous antibody-based therapeutics are currently undergoing clinical trials.
  • Several antibodies are successfully utilized in treating various cancers.

Conclusions:

  • Monoclonal antibodies represent a significant advancement in cancer treatment.
  • The development of targeted antibody therapies presents both opportunities and challenges.
  • Continued innovation is expected to yield more antibody-based cancer treatments in the near future.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...